http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2007013021-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
filingDate 2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d87ed2bee31eab5f648893b2043a73e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713d5d43e7a2b1b039027909be71e316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59a12885ea105b0ad171910f0b6fda5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349bd4567594c395aaf17538182a7b31
publicationDate 2008-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2007013021-A
titleOfInvention DERIVATIVES OF BENZOFURANIL-ALCANAMINE AND USES OF THE SAME AS AGONISTS OF 5-HT2C.
abstract A compound of formula I or pharmaceutically acceptable salts thereof is provided; wherein each of R1, R1, R2, R3, R4, n and Ar are as defined in the description that they are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of disorders of the central nervous system such as schizophrenia.
priorityDate 2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457626896

Total number of triples: 34.